You are here:
Home 
In The News Cardiology ARBs Associated with Reduced Dementia and Alzheimer Disease Risk
In The News Cardiology ARBs Associated with Reduced Dementia and Alzheimer Disease Risk
Belize Medical and Dental Association - www.BmdaDrs.com - aims an objectives include: To compile a comprehensive directory of physicians and dentists residing in Belize. To promote the interest of physicians and dentists in Belize. To support physicians and dentists, as well as other brilliant and deserving professionals pursuing their careers in those fields or any other fields in Belize and else where.
|
In The News Cardiology ARBs Associated with Reduced Dementia and Alzheimer Disease Risk
| ARBs Associated with Reduced Dementia and Alzheimer Disease Risk |
 |
 |
 |
| Posted by Dr. Johanne Perez M.D |
| Friday, 12 February 2010 16:17 |
|
Physician's First Watch for January 13, 2010 David G. Fairchild, MD, MPH, Editor-in-Chief Angiotensin-receptor blockers (ARBs) are associated with reduced risk for dementia and Alzheimer disease, according to a BMJ study.
BMJ article (Free) |
Researchers analyzed Veterans Affairs records of 800,000 mostly male patients aged 65 and older with cardiovascular disease. Over the 4-year observation period, patients taking ARBs were less likely to develop dementia or Alzheimer disease, to be admitted to a nursing home, or to die than were patients taking the ACE-inhibitor lisinopril or other cardiovascular drugs, such as beta-blockers or calcium channel antagonists. Patients taking both ARBs and ACE-inhibitors saw a further risk reduction.
